Neoadjuvant hormone therapy for patients with high-risk prostate cancer: a systematic review and meta-analysis

Neoadjuvant hormone therapy for patients with high-risk prostate cancer: a systematic review and meta-analysis

This study aimed to identify the pathological outcomes and survival benefits of neoadjuvant hormone therapy (NHT) combined with radical prostatectomy (RP) and radiotherapy (RT) administered to patients with high-risk prostate cancer (HRPCa). We searched PubMed, Embase, and the Cochrane Library for s...

Full description

Bibliographic Details
Main Authors: Wen Liu, Yu Yao, Xue Liu, Yong Liu, Gui-Ming Zhang
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Asian Journal of Andrology
Subjects:
high-risk diseases; meta-analysis; neoadjuvant hormone therapy; prostate cancer; prostatectomy; radiotherapy
Online Access:http://www.ajandrology.com/article.asp?issn=1008-682X;year=2021;volume=23;issue=4;spage=429;epage=436;aulast=Liu

Internet

http://www.ajandrology.com/article.asp?issn=1008-682X;year=2021;volume=23;issue=4;spage=429;epage=436;aulast=Liu

Similar Items